| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Behandlung des Hörsturzes durchFibrinogen-LDL-Apherese - Fibrinogen/LDL-apheresis in thetreatment of sudden hearing loss: A prospective, randomizedmulticenter trial
|
Suckfüll, M.
|
|
2003
|
92 |
3 |
p. iii59-iii63
|
article
|
| 2 |
Coronary artery bypass grafting in patients with systemic lupus erythematosus - Koronarchirurgie bei Patienten mit Lupus erythematodes
|
Bossert, T.
|
|
2003
|
92 |
3 |
p. 219-221
|
article
|
| 3 |
Coronary artery bypass grafting in patients with systemic lupus erythematosus - Koronarchirurgie bei Patienten mit Lupus erythematodes
|
Bossert, T.
|
|
2003
|
92 |
3 |
p. 219-221
|
article
|
| 4 |
Die Rolle des intravasalenUltraschalls zur Beurteilung derTransplantvaskulopathie - Intravascular ultrasound examinationfor the assessment of graft vasculopathy
|
Braun, P.
|
|
2003
|
92 |
3 |
p. iii48-iii52
|
article
|
| 5 |
Die total arterielle Myokardrevaskularisation – Strategie, kurz- und mittelfristige Ergebnisse - Total arterial myocardial revascularization – strategy, early and midterm results
|
Vicol, Calin
|
|
2003
|
92 |
3 |
p. 222-228
|
article
|
| 6 |
Die total arterielle Myokardrevaskularisation – Strategie, kurz- und mittelfristige Ergebnisse - Total arterial myocardial revascularization – strategy, early and midterm results
|
Vicol, Calin
|
|
2003
|
92 |
3 |
p. 222-228
|
article
|
| 7 |
Erratum: Z Kardiol 92:96–103 (2003)
|
,
|
|
2003
|
92 |
3 |
p. 278
|
article
|
| 8 |
Erratum: Z Kardiol 92:96–103 (2003)
|
|
|
2003
|
92 |
3 |
p. 278
|
article
|
| 9 |
H.E.L.P.-Apherese und oxidativerStress - H.E.L.P. aphresis and oxidativestress
|
Pulawski, E.
|
|
2003
|
92 |
3 |
p. iii38-iii41
|
article
|
| 10 |
Heparininduzierte extrakorporaleLDL-Präzipitation (H.E.L.P.) - Heparin-induced extracorporeal LDLprecipitation (H.E.L.P.)
|
Horstkotte, D.
|
|
2003
|
92 |
3 |
p. iii1-iii5
|
article
|
| 11 |
Kardiales Risiko bei Männern mit angiographisch normalen oder minimal arteriosklerotisch veränderten Koronararterien - Cardiac risk in men with angiographically normal coronary arteries or minimal coronary arteriosclerosis
|
Schulz, H.
|
|
2003
|
92 |
3 |
p. 245-253
|
article
|
| 12 |
Kardiales Risiko bei Männern mit angiographisch normalen oder minimal arteriosklerotisch veränderten Koronararterien - Cardiac risk in men with angiographically normal coronary arteries or minimal coronary arteriosclerosis
|
Schulz, H.
|
|
2003
|
92 |
3 |
p. 245-253
|
article
|
| 13 |
Kein Nachweis von Chlamydia pneumoniae in normalen und atherosklerotischen Femoralarterien mittels Polymerase-Kettenreaktion (PCR) – eine autoptische Studie - No detection of Chlamydia pneumoniae in normal and atherosclerotic femoral arteries by polymerase chain reaction (PCR) – an autopsy study
|
Wessely, Simone
|
|
2003
|
92 |
3 |
p. 229-235
|
article
|
| 14 |
Kein Nachweis von Chlamydia pneumoniae in normalen und atherosklerotischen Femoralarterien mittels Polymerase-Kettenreaktion (PCR) – eine autoptische Studie - No detection of Chlamydia pneumoniae in normal and atherosclerotic femoral arteries by polymerase chain reaction (PCR) – an autopsy study
|
Wessely, Simone
|
|
2003
|
92 |
3 |
p. 229-235
|
article
|
| 15 |
Kosten und Kosteneffektivität von Eptifibatid in der Behandlung des akuten Koronarsyndroms - Costs and cost-effectiveness of Eptifibatide in the treatment of coronary ischemic syndromes. An analysis based on the PURSUIT study
|
Szucs, Thomas D.
|
|
2003
|
92 |
3 |
p. 236-244
|
article
|
| 16 |
Kosten und Kosteneffektivität von Eptifibatid in der Behandlung des akuten Koronarsyndroms - Costs and cost-effectiveness of Eptifibatide in the treatment of coronary ischemic syndromes. An analysis based on the PURSUIT study
|
Szucs, Thomas D.
|
|
2003
|
92 |
3 |
p. 236-244
|
article
|
| 17 |
Langzeitergebnisse mit derH.E.L.P.-Apherese - Clinical long-term results ofH.E.L.P.-apheresis
|
Schuff-Werner, P.
|
|
2003
|
92 |
3 |
p. iii28-iii29
|
article
|
| 18 |
LDL-Apherese bei derhyperchylomikronämieinduzierten Pankreatitis - LDL-Apheresis for the treatment ofhyperchylomicronemia-induced pancreatitis
|
Sattler, A. M.
|
|
2003
|
92 |
3 |
p. iii64-iii67
|
article
|
| 19 |
Leserbrief
|
,
|
|
2003
|
92 |
3 |
p. 276-277
|
article
|
| 20 |
Leserbrief
|
|
|
2003
|
92 |
3 |
p. 276-277
|
article
|
| 21 |
Lipoprotein(a) - Lipoprotein(a): Aspects ofpathophysiology, epidemiology and treatment
|
Thomas, H.-P.
|
|
2003
|
92 |
3 |
p. iii53-iii58
|
article
|
| 22 |
Mitteilungen der Deutschen Gesellschaft für Kardiologie - Herz- und Kreislaufforschung
|
,
|
|
2003
|
92 |
3 |
p. 279-282
|
article
|
| 23 |
Mitteilungen der Deutschen Gesellschaft für Kardiologie - Herz- und Kreislaufforschung
|
|
|
2003
|
92 |
3 |
p. 279-282
|
article
|
| 24 |
Myokardiale Perfusion unterH.E.L.P.-Apherese - Myocardial perfusion under H.E.L.P.apheresis measured by positron emissiontomography
|
Mellwig, K.-P.
|
|
2003
|
92 |
3 |
p. iii30-iii37
|
article
|
| 25 |
Pharmacodynamic and clinical trials of glycoprotein IIb/IIIa inhibitors and potential relationship of results to dosing - Der Einfluss der Dosierung auf die Ergebnisse pharmakodynamischer und klinischer Studien mit Glycoprotein IIb/IIIa Inhibitoren
|
Hobbach, Hans-Peter
|
|
2003
|
92 |
3 |
p. 213-218
|
article
|
| 26 |
Pharmacodynamic and clinical trials of glycoprotein IIb/IIIa inhibitors and potential relationship of results to dosing - Der Einfluss der Dosierung auf die Ergebnisse pharmakodynamischer und klinischer Studien mit Glycoprotein IIb/IIIa Inhibitoren
|
Hobbach, Hans-Peter
|
|
2003
|
92 |
3 |
p. 213-218
|
article
|
| 27 |
Primäres Adenokarzinom des linken Herzvorhofes - Primary adenocarcinoma of the left atrium mimicking benign myxoma
|
Schnabel, Renate
|
|
2003
|
92 |
3 |
p. 254-259
|
article
|
| 28 |
Primäres Adenokarzinom des linken Herzvorhofes - Primary adenocarcinoma of the left atrium mimicking benign myxoma
|
Schnabel, Renate
|
|
2003
|
92 |
3 |
p. 254-259
|
article
|
| 29 |
QUASA—DasApherese-Register - QUASA—theapheresisregistry
|
Dräger, J.
|
|
2003
|
92 |
3 |
p. iii68-iii72
|
article
|
| 30 |
Stellenwert der LDL-Apherese in derBehandlung der koronaren Herzerkrankung - LDL-apheresis in the treatment ofcoronary heart disease. Rationale for a specific adjuvanttherapy
|
Seidel, D.
|
|
2003
|
92 |
3 |
p. iii6-iii27
|
article
|
| 31 |
Ulzerierter LCA-Hauptstamm-Plaque: IVUS-geführte Diagnose nach transmuraler Vorderwand-Ischämie und kardiogenem Schock - Intravascular ultrasound-guided diagnosis after transmural anterior ischemia and cardiogenic shock
|
Lüdorff, G.
|
|
2003
|
92 |
3 |
p. 267-272
|
article
|
| 32 |
Ulzerierter LCA-Hauptstamm-Plaque: IVUS-geführte Diagnose nach transmuraler Vorderwand-Ischämie und kardiogenem Schock - Intravascular ultrasound-guided diagnosis after transmural anterior ischemia and cardiogenic shock
|
Lüdorff, G.
|
|
2003
|
92 |
3 |
p. 267-272
|
article
|
| 33 |
Ungewöhnliches Leriche-Syndrom - Atypical Leriche syndrome
|
Bresan, Viola
|
|
2003
|
92 |
3 |
p. 260-266
|
article
|
| 34 |
Ungewöhnliches Leriche-Syndrom - Atypical Leriche syndrome
|
Bresan, Viola
|
|
2003
|
92 |
3 |
p. 260-266
|
article
|
| 35 |
Verbindung zwischen nichtstenosierten Herzkranzarterien - Communication between nonstenotic coronary arteries
|
Dübel, H.-P.
|
|
2003
|
92 |
3 |
p. 273-275
|
article
|
| 36 |
Verbindung zwischen nichtstenosierten Herzkranzarterien - Communication between nonstenotic coronary arteries
|
Dübel, H.-P.
|
|
2003
|
92 |
3 |
p. 273-275
|
article
|
| 37 |
Verhinderung von Frühverschlüssennach koronarer Bypassoperation durch postoperative Reduktion desPlasmafibrinogens mittels H.E.L.P.-Apherese - Prevention of early graft occlusionafter coronary bypass grafting by post-operative reduction ofplasma fibrinogen by H.E.L.P. apheresis
|
Blessing, F.
|
|
2003
|
92 |
3 |
p. iii42-iii47
|
article
|
Journal description